AI takes the wheel: could a smart algorithm optimize insulin pumps from home?

NCT ID NCT07732777

First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time

Summary

This trial tests whether an artificial intelligence system can help optimize insulin pump settings remotely for people with type 1 diabetes. The AI analyzes continuous glucose monitor and pump data to suggest personalized adjustments, which a doctor then reviews before sending to the participant's phone. The study compares this AI-assisted approach to standard pump therapy to see if it improves time-in-range blood sugar levels.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
AI-assisted insulin pump settings optimization system
What this could lead to
If successful, this approach could make insulin pump management easier and more effective for people with type 1 diabetes, potentially improving blood sugar control without extra clinic visits.
What could go wrong
This is a small, early-stage trial with only 50 participants. The AI recommendations still require physician approval, so any benefit may depend on how well the system works in real-world conditions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES (T1D) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Department of Endocrinology

    RECRUITING

    Nanjing, Jiangsu, 210008, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.